Scientific Advisory Board

Phillip Dennis, MD PhD

Vice President, Disease Strategy Head, Lung Cancer, AstraZenecaGlobal Clinical Lead, Lung Cancer Immuno-Oncology

Dr Dennis is the Vice-President and Head of Disease Strategy Head of Lung Cancer at AstraZeneca. He was previously Director of the Center of Excellence in Thoracic Oncology at Johns Hopkins and the Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Bayview. Prior to these roles, he was a Senior Investigator at the US National Cancer Institute, where his research focused on the role of the PTEN/PI3K/Akt pathway in cancer and the development of therapies for cancers and those who live with PHTS. He is an elected member of the American Society for Clinical Investigation.



Phillip Dennis, MD PhD Image

Sign up for our newsletter